Zinc supplement shorten the duration of common colds

Conflicting results across studies: While the average across 6 studies suggests zinc shortens colds by ~2 days, the largest single trial (279 participants) found no benefit — results vary too widely to draw a firm conclusion

High statistical inconsistency: The I²=83% means studies disagree substantially — likely because zinc formulation, dose, and timing all change the outcome dramatically

Low certainty rating: The study authors themselves rated the evidence quality as low using the standard GRADE framework — meaning we cannot be confident the true effect matches the estimate

Bottom line: The math points toward benefit, but the studies disagree too much with each other to confidently say zinc reliably shortens colds for most people.

Specific formulation, not "zinc supplements": This study only tested high-dose zinc acetate lozenges dissolved in the mouth — results cannot be applied to zinc pills, nasal sprays, or lower-dose products found in most stores

Weak statistical reporting: No p-values were reported for the main result; significance is inferred from confidence intervals only, and the largest trial (n=101) barely reached significance on its own

Small, self-referential evidence base: Only 199 patients across 3 trials — all co-authored by the same researchers who conducted the original trials, with no independent pre-registered protocol

Directional signal exists but is fragile: All three trials showed reduced cold duration, but effect sizes varied widely (25–45%) and the pooled estimate is driven by two small trials with unusually low variability

Bottom line: Promising signal for a specific zinc formulation, but methodological limitations prevent a confident conclusion — classified as Inconclusive

The studies included are too different from each other (different zinc types, doses, delivery methods) to pool meaningfully — a statistical measure called I² reached 97%, far above the 50% threshold for concern

Key red flag: When only the better-designed studies are kept, the effect on cold duration disappears entirely — suggesting the positive result is driven by lower-quality research

What the paper actually says: The Cochrane authors themselves conclude the evidence is "insufficient to provide firm conclusions or recommend zinc supplementation"

Bottom line: Despite a surface-level positive result, the underlying data quality is too unreliable to confidently say zinc supplements shorten colds